Galderma will present the latest updates from its innovative aesthetics portfolio at the International Master Course on Aging Science (IMCAS) World Congress 2025 on January 30 ? February 1 in Paris, ...

Galderma, the world leader in dermatology and skin care, is seeking to answer this question by pushing forward on its ongoing advancements in aesthetics through scientific research and innovation ...

It is encouraging to see these early results, which demonstrate the potential of our existing Injectable Aesthetics portfolio in addressing the effects of medication-driven weight loss on the skin, ...

Baby boomers and users of weight loss drugs suffering from “facial sagging” are flocking to injectable aesthetic treatments ...

PARIS - Beauty M&A may be slow Stateside, but global IPO season is about to kick off - again. Initial public offerings were ...

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including ...

A dermatology group has reported a 'signficant uptick' in filler sales due to 'Ozempic face' – facial sagging caused by the ...

Galderma (SWX:GALD) announced today the launch of its hyaluronic acid injectable filler, Restylane ® VOLYMEtm in China. The company is also introducing its complementary Shape Up Holistic ...

(BUSINESS WIRE )--Galderma (SWX:GALD) announces positive first results from a trial designed to explore the benefits of Restylane® LyftTM or ContourTM in combination with Sculptra® in patients ...

DUBLIN--(BUSINESS WIRE)--The "Indonesia Medical Aesthetics Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Indonesia Medical Aesthetics Market ...

Galderma successfully placed an inaugural bond with a total amount of CHF 500 million through a dual tranche offering: ...